Under the leadership of Dr. Monica Campo, MD, MPH, a distinguished physician-scientist and pulmonary critical care expert at the University of Minnesota Medical School, the study leverages cutting-edge immunological methodologies to scrutinize the behavior of lung macrophages—critical immune cells orchestrating the host response against invading pathogens. By focusing on these cells, the team seeks to illuminate the immunological crosstalk that either facilitates containment of Mycobacterium tuberculosis or permits its unchecked proliferation.

Tuberculosis, a disease historically associated with high morbidity and mortality worldwide, initially establishes itself in the lungs. Yet, the precise molecular and cellular events determining whether an exposed individual successfully restricts infection or progresses towards active disease have remained elusive. Dr. Campo highlights this knowledge gap, asserting that “the earliest immune events at the level of the lung microenvironment are the linchpins governing infection control.” The research aspires to pinpoint specific macrophage activation states and gene expression profiles that correspond with protective immune signatures.

Integral to this endeavor is the collaboration with the Hennepin County Tuberculosis Clinic, a clinical partner facilitating patient recruitment and sample acquisition. The research will employ advanced single-cell sequencing technologies, innovative flow cytometry panels, and spatial transcriptomics, enabling unprecedented resolution of immune cell subsets and their functional states within infected lung tissue. By dissecting these cellular phenotypes, the team hopes to identify macrophage subsets that serve as frontline defenders against tuberculosis.

The implications of these findings transcend basic science, holding promise for informing novel prophylactic strategies and therapeutic interventions. Understanding macrophage programs that promote early bacterial clearance could pave the way for next-generation vaccines or immune-modulatory drugs targeted at enhancing lung-resident immunity. Such advancements bear global significance, given tuberculosis’s status as one of the world’s deadliest infectious diseases.

This ambitious project also exemplifies translational research, bridging molecular immunology with clinical infectious disease practice. Dr. Campo, who simultaneously manages a pulmonary critical care practice within M Health Fairview, underscores the translational impact: “Our objective is to generate insights that directly inform prevention approaches, ultimately reducing the burden of tuberculosis in vulnerable populations.”

As the study progresses, participant recruitment, slated to commence later this year, will focus on individuals recently exposed to tuberculosis. Longitudinal sampling and analysis will provide temporal insight into macrophage response evolution, offering clues into the mechanisms that tip the balance towards infection control or progression. This temporal dimension is critical for defining windows of opportunity for intervention.

Moreover, the research taps into emerging paradigms recognizing the lung as a complex immunological niche where cellular heterogeneity and local cues intricately dictate infection outcomes. Macrophages, as versatile phagocytes, exhibit remarkable plasticity, adapting their functions in response to microenvironmental signals. Decoding this plasticity in the context of tuberculosis exposure is central to identifying biomarkers and therapeutic targets.

The commitment of the University of Minnesota Medical School to advancing biomedical research is further evidenced through this initiative, aligning with its mission to refine medical knowledge and healthcare delivery. Acknowledging the institution’s location on the traditional lands of the Dakota and Ojibwe peoples, the research also underscores a respectful engagement with Indigenous communities disproportionately affected by tuberculosis.

In sum, this cutting-edge investigation promises to unravel the enigmatic early immune orchestration within the lung during tuberculosis exposure. The convergence of sophisticated immunological tools, clinical collaboration, and expert leadership positions this program to yield transformative insights, potentially reshaping the global fight against tuberculosis.

Subject of Research: Early immune responses in the lung macrophages influencing tuberculosis infection outcomes
Article Title: University of Minnesota Secures Major NIH Grant to Unveil Lung Macrophage Roles in Tuberculosis Control
News Publication Date: June 8, 2026
Web References: https://med.umn.edu/bio/monica-campo-patino; https://med.umn.edu/
Keywords: Tuberculosis, Immune response, Macrophages, Lung immunity, Infectious diseases, Pulmonary immunology, Mycobacterium tuberculosis, Clinical research, Single-cell sequencing, Immunological plasticity, Translational medicine, Infectious disease prevention

Tuberculosis continues to be the leading cause of death attributed to a single infectious pathogen worldwide, primarily propagated by the bacterium Mycobacterium tuberculosis. The pathogen predominantly infects macrophages—specialized immune cells designed to engulf and destroy microbes. Intriguingly, not all macrophages become infected when exposed to TB bacteria. Decoding the underlying factors that render certain macrophages vulnerable while others remain unscathed is a critical challenge that could translate directly into more effective therapeutic interventions.

The research team’s innovative method leverages liquid chromatography-mass spectrometry (LC-MS) applied at the single-cell level, a feat previously unattainable due to the diminutiveness of human cells—typically about 10 micrometers in diameter with volumes less than a picoliter, a scale roughly 100 million times smaller than a drop of rain. This technique allows scientists to isolate individual macrophages under a microscope, preserving their native state and immediate microenvironment. Through LC-MS, they then generate a unique metabolic “fingerprint” for each cell, mapping a complex profile of metabolites—the small molecules involved in chemical reactions that sustain life.

This single-cell metabolic fingerprinting provides unparalleled insight into the biochemical landscape inside every cell, highlighting nuanced differences between infected and uninfected macrophages. Such minute differences would invariably be obscured by conventional methods, which typically aggregate and analyze large populations of cells, thereby masking cell-to-cell variability and the heterogeneity fundamental to biological systems.

Unlike previous approaches that analyzed mixed cell populations or sorted groups of cells, this technique maintains spatial context, enabling researchers not only to compare the biochemical states of individual cells but also to understand their positional relationships within tissues. Understanding how infected cells might communicate stress or danger signals to neighboring uninfected cells could illuminate new pathways of immune system coordination or failure during TB infection.

Dr. Abigail Cook, a PhD student and lead author, emphasized the breakthrough’s precision: “We have pushed the limits of detection to explore metabolic differences within single cells, despite their incredibly small volumes. This level of resolution is essential to discerning how infection transforms cellular chemistry at the most fundamental unit of life.”

Central to this technological achievement is the development of a microscopy-coupled LC-MS workflow that delicately isolates single macrophages directly from biological samples. By preserving the metabolic state during extraction, the team ensures accurate representation of intracellular processes without artifacts introduced by batch processing or cell sorting. This meticulous methodology enables the detection of low-abundance metabolites that are crucial indicators of cellular response to TB bacteria.

The implications of this research extend beyond TB. Professor Melanie Bailey, senior author and Professor in the Physical Sciences of Life at King’s College London, notes that the method could revolutionize studies of not only bacterial infections but also viral, fungal, and cancerous conditions. “It’s transformative to link a cell’s visible morphology to its detailed metabolic chemistry,” Bailey explains, “expanding our ability to interrogate fundamental biology and disease mechanisms at single-cell resolution.”

A key collaborative strength underpinning this study lies at the intersection of chemistry and biology. Dr. Dany Beste from the University of Surrey, a microbial metabolism specialist and co-author, remarks on the synergy between disciplines: “Integrating expertise in microbial biochemistry and chemical analysis enabled us to tackle questions impossible to answer from a single viewpoint. Such interdisciplinary collaboration is vital for scientific breakthroughs.”

Looking ahead, the research group plans to harness the capabilities of the SEISMIC Facility at King’s College London, a state-of-the-art center dedicated to single-cell and sub-cellular omics, to extend the application of this technique. Future investigations aim to elucidate how metabolic alterations within infected macrophages influence disease progression, antimicrobial resistance, and immune signaling networks, potentially guiding the development of novel diagnostics and targeted therapies.

Supported by funding from the Doctoral College at the University of Surrey, Yokogawa Electric Corporation, the Engineering and Physical Sciences Research Council (EPSRC), and the Biotechnology and Biological Sciences Research Council (BBSRC), this work represents a significant leap forward in cellular microbiology and analytical chemistry integration.

As the global fight against tuberculosis continues, this pioneering approach equips scientists with a powerful new lens to decode the cellular dialogues that underlie infection and immunity, driving forward hopeful strategies to curb one of humanity’s deadliest infectious diseases.

Subject of Research: Cells
Article Title: Revolutionary Single-Cell Metabolic Analysis Illuminates Tuberculosis Infection at the Cellular Level
News Publication Date: Not specified
Web References: https://pubs.acs.org/doi/10.1021/acs.analchem.5c06318, https://www.kcl.ac.uk/research/facilities/the-seismic-facility-for-single-and-sub-cellular-omics
References: Supported by Doctoral College at University of Surrey, Yokogawa Electric Corporation, EPSRC, BBSRC
Image Credits: Not provided
Keywords: Tuberculosis, Single-cell analysis, Macrophages, Metabolism, Liquid chromatography-mass spectrometry (LC-MS), Cellular metabolism, Infectious diseases, Mycobacterium tuberculosis, Host-pathogen interaction, Analytical chemistry, Microbial metabolism, Cell biology